Study Links Menopause Hormone Therapy to Greater Weight Loss With Certain GLP-1 Drugs
Mayo Clinic researchers found that women using hormone therapy experienced greater average weight loss while taking semaglutide, compared with nonusers.

Hormone replacement therapy may be associated with differences in weight loss outcomes among women using GLP-1-based obesity medications, according to research presented by scientists at Mayo Clinic Florida. The findings highlight the potential role of estrogen in shaping treatment responses among women experiencing menopause.
The retrospective study examined electronic medical records belonging to overweight and obese women aged 45 and older who had received prescriptions for semaglutide or tirzepatide, two medications increasingly used in obesity treatment.
Semaglutide is marketed under brand names including Ozempic and Wegovy, while tirzepatide is available as Mounjaro and Zepbound. Researchers divided participants according to whether they were receiving menopause hormone therapy, allowing them to examine differences in weight loss outcomes between the groups.
The semaglutide analysis included 2,379 women, while the tirzepatide group consisted of 1,476 participants. To improve the comparability of the results, researchers applied propensity score matching, accounting for factors including age, body mass index, previous obesity medication use and Type 2 diabetes status.
One of the most notable findings involved women taking semaglutide. Participants receiving hormone therapy experienced significantly greater weight reduction beginning at the nine-month mark compared with women who were not using hormonal treatment.
After 15 months, women combining semaglutide with menopause hormone therapy had lost an average of 11.6% of their initial body weight. The corresponding figure among women not receiving hormone therapy was 9.7%.
The difference suggests that hormonal changes associated with menopause may be relevant when evaluating responses to obesity treatments. Estrogen is involved in several processes related to metabolism and body weight regulation, making it an important area for further investigation.
However, the findings establish an association rather than proving that hormone therapy directly causes additional weight loss. The retrospective design also means that researchers examined existing medical records rather than assigning participants to specific treatments through a controlled clinical trial.
The research adds to ongoing scientific interest in understanding why individuals respond differently to GLP-1 medications. Further investigation will be necessary to determine whether similar patterns occur across different patient populations and treatment options.

News You Should See
Seattle Communities Celebrate Holiday Season with Local Markets and Cultural Activities
Nvidia's AI Dominance Faces Conflicting Expectations as Industry Demand Accelerates
Signal Strengthens Mobile Privacy Protections Amid Growing AI Surveillance Concerns
AI Agents Transform Messaging Apps Into Everyday Digital Assistants
Roma Crush Parma 5-1 as Donyell Malen Scores Four Goals
Vivo Prepares Three New Budget Smartphones with 6,500mAh Batteries and Updated Features
Latest News
Explore holiday markets, handmade gifts, live music, and cultural events in Shoreline and Lake Forest Park, Washington, on November 22.
Nvidia faces contrasting industry expectations as AI demand grows, with its financial performance and leadership shaping the future of computing.
Signal introduces mobile screenshot restrictions on Android and iOS as concerns grow over AI-powered surveillance and digital privacy.
AI agents are transforming messaging platforms by helping users organize daily activities, plan travel, manage work, and complete everyday tasks.
Donyell Malen scores four goals as Roma defeat Parma 5-1, while Lazio beat Lecce 3-0 in another important Serie A result.
Vivo's upcoming budget phones reportedly feature 6,500mAh batteries, 6.74-inch displays and different camera and charging specifications.
Carlos Espi scores a late winner as Real Madrid defeat Celta Vigo 2-1, despite Kylian Mbappé missing a penalty.
Google Pixel 11 reportedly features the Tensor G6 processor, 256GB storage and 25W wireless charging, alongside familiar camera and display features.
Felix Nmecha plays a crucial role as Borussia Dortmund defeat Borussia Mönchengladbach, strengthening their Bundesliga campaign.
